NewAmsterdam Pharma (NAMS, $23.37) RSI Indicator left the overbought zone on March 10, 2025

#Biotechnology, #TechnicalAnalysis, #RSI, #Bearish, #Stocks, #MidCap
NAMS - NewAmsterdam Pharma Company NV
RSI signal
Bearish Trend
63%
Odds of DOWN Trend
Price: $23.37
Daily change: -$0.43 (-1.81%)
Daily volume: 1M
Industry: Biotechnology

This is a signal that NAMS's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options. A.I.dvisor looked back and found 30 similar cases where NAMS's RSI Indicator left the overbought zone, and in 19 of them led to a successful outcome. Odds of Success: 63%.